General Information of the Compound
| Compound ID |
CP0434903
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N,N'-bis[3-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]icosanediamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C56H74Cl2N10O2
|
||||||||||||||||||
| Molecular Weight |
990.182
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN(CC1)C1=Nc2cc(Cl)ccc2N(NC(=O)CCCCCCCCCCCCCCCCCCC(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc23)c2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C56H74Cl2N10O2/c1-63-33-37-65(38-34-63)55-45-23-19-21-25-49(45)67(51-31-29-43(57)41-47(51)59-55)61-53(69)27-17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-28-54(70)62-68-50-26-22-20-24-46(50)56(66-39-35-64(2)36-40-66)60-48-42-44(58)30-32-52(48)68/h19-26,29-32,41-42H,3-18,27-28,33-40H2,1-2H3,(H,61,69)(H,62,70)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YDINFSKVJZVGLK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound